AI Visibility Scorecard
Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT
orfadin.com · Healthcare
Borderline visible. AI bots can crawl Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 4 times
Claude · Apple Intelligence · ShapBot
#46,659 of 924,420 in Healthcare for AI visibility
2
4
AEO Visibility
iBorderline · 4.2/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
About Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT
from our crawl and measurement
Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT is a business whose own site puts it this way: "Learn about Orfadin® (nitisinone), the first FDA-approved treatment for hereditary tyrosinemia type 1 (HT-1), and our patient support services." When AI engines look at it, they find little to work with. It scores 4.2 out of 10.
The site is missing structured data describing the business, an llms.txt file and a sitemap.
AI crawlers have visited 2 times in our tracking, including ClaudeBot (Anthropic) and Applebot (Siri).
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Good
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.2/10, Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT.
Source & Attribution
Scored by Engagemii on August 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/orfadin
Cite this score: Engagemii (2026). "AEO Score for Orfadin® (nitisinone) for hereditary tyrosinemia type 1 (HT." Retrieved from https://engagemii.com/aeo/brands/orfadin
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform